MYGN
Myriad Genetics Stock Analysis
AI Rating
- Quality4/10
- Growth↓ 0/10
- Momentum↓ 1/10
MYGN Growth
- Revenue Y/Y↓ 0.21%
- EPS Y/Y↓ -238.28%
- FCF Y/Y↑ 72.51%
MYGN Profitability
- Gross margin ↑ 70.40%
- EPS margin↓ -48.50%
- ROIC↓ -111.80%
MYGN Risk
- Debt / Equity↓ 0.6
- Debt / FCF↓ 2.3
- Interest coverage↓ -61.5
Myriad Genetics stock volatility is in-line with the overall market. We give it a Great risk rating.